The pathogenesis of thyroid cancer is linked to the constitutive activation of key signaling pathways, including the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-kinase/Akt (PI3K/AKT) pathways, which promote thyroid cell growth, proliferation, and survival (4). Here, AKT1 is linked to thyroid cancer.